These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids. Gupta RK, Siber GR. Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950 [Abstract] [Full Text] [Related]
6. Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children. Scheifele DW, Meekison W, Grace M, Barreto L, Carter AO, Mitchell L, Farley J. CMAJ; 1991 Sep 15; 145(6):641-7. PubMed ID: 1893319 [Abstract] [Full Text] [Related]
7. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Halperin SA, King J, Law B, Mills E, Willems P. Clin Infect Dis; 1999 May 15; 28(5):995-1001. PubMed ID: 10452624 [Abstract] [Full Text] [Related]
8. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants. Chotpitayasunondh T, Panpitpat C, Thisyakorn U, Furer E, Que JU, Hasler T, Cryz SJ. Southeast Asian J Trop Med Public Health; 1997 Mar 15; 28(1):91-8. PubMed ID: 9322290 [Abstract] [Full Text] [Related]
9. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ. Vaccine; 2006 Mar 10; 24(11):1776-85. PubMed ID: 16303216 [Abstract] [Full Text] [Related]
10. [The immunological basis of the administration of DTP-polio vaccine]. Cohen H. Verh K Acad Geneeskd Belg; 2000 Mar 10; 62(4):245-67. PubMed ID: 11004905 [Abstract] [Full Text] [Related]
13. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Hla KH, Thein SA, Aye A, Han HH, Bock HL, David MP, Schuerman L. Pediatr Infect Dis J; 2006 Aug 10; 25(8):706-12. PubMed ID: 16874170 [Abstract] [Full Text] [Related]
15. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine. Gupta RK, Anderson R, Cecchini D, Rost B, Xu J, Gendreau K, Saroff DL, Marchant C, Siber GR. Biologicals; 1999 Jun 10; 27(2):167-76. PubMed ID: 10600208 [Abstract] [Full Text] [Related]
16. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia. Viviani S, Mendy M, Jack AD, Hall AJ, Montesano R, Whittle HC. Trop Med Int Health; 2004 Oct 10; 9(10):1044-9. PubMed ID: 15482396 [Abstract] [Full Text] [Related]
17. [Quadrivalent vaccine against diphtheria, tetanus, B. pertussis and hepatitis B: experience in Spain]. González López A, Arístegui Fernández J, Díez-Delgado J, Dal-Ré Saavedra R. An Esp Pediatr; 1998 Feb 10; 48(2):132-7. PubMed ID: 9577019 [Abstract] [Full Text] [Related]
18. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine. Lin TY, Wang YH, Huang YC, Chiu CH, Lin PY, Chen CJ, Chavand P, Ortiz E. Int J Infect Dis; 2007 Nov 10; 11(6):488-95. PubMed ID: 17349809 [Abstract] [Full Text] [Related]
19. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults. Chan SH, Tan PT, Han HH, Bock HL. Singapore Med J; 2006 Apr 10; 47(4):286-90. PubMed ID: 16572239 [Abstract] [Full Text] [Related]
20. The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins. Robbins JB, Schneerson R, Trollfors B, Sato H, Sato Y, Rappuoli R, Keith JM. J Infect Dis; 2005 Jan 01; 191(1):81-8. PubMed ID: 15593007 [Abstract] [Full Text] [Related] Page: [Next] [New Search]